Natural product-derived therapy for overcoming chemoresistance in Human cancers: Honokiol increases the expression of CADM1, decreases BMI1 translocation, increases tumor suppressor INK4a/p16 expression and restores chemosensitivity in drug-resistant Human cancers via down regulation of its target gene, 18/December/2016, 11.01 pm

Immune enhancement therapy: Annexin A2 (Anxa2) increases SOX2 expression and promotes innate immunity against bacterial infection via down-regulation of its target gene, 18/December/2016, 10.52 pm
December 18, 2016
Natural product-derived therapy for enhancing anti-cancer immunity: Curcumin analog EF24 decreases the level of LATS1/2 (large tumor suppressor 1 and 2), increases immunogenicity of tumors, enhances anti-tumor immune responses, and inhibits tumor growth via down regulation of its target gene, 19/December/2016, 10.27 am
December 19, 2016
Show all

From Research findings to Therapeutic opportunity: 

The study presented here suggests that Honokiol, by increasing the expression of its target genes, it may: (i) increase the expression of CADM1; (ii) decrease BMI1 translocation; (iii) increase tumor suppressor INK4a/p16 expression; and (iv) restore chemosensitivity in drug-resistant Human cancers (Fig 1.).

price-5

[easy_payment currency=”USD”]

Thereby, it may inhibit proliferation, chemoresistance and apoptosis of cancer cells. Thus, pharmacological formulations encompassing “Honokiol or its analogues or Honokiol in combination with any of known anti-cancer drugs” (fig. 2) may be used to inhibit cancer progression.

Honokiol inhibits human cancer cell proliferation via down regulation of Tripeptidyl Peptidase 1 (TPP1) and telomerase

Figure 1 Honokiol, isolated from Magnolia grandiflora/dealbata/obovata/officinalis, increases the expression of CADM1, inhibits BMI-1 translocation, increases tumor suppressor INK4a/p16 expression and inhibits chemoresistance via up-regulation of its target gene

 

 

Honokiol

Figure 2. Honokiol


Details of the research findings

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Undisclosed information: How Honokiol increases the expression of CADM1, and INK4a/p16?

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $5

For purchase and payment details, you may reach us at info@genomediscovery.org


References

CitationBoominathan, L., Natural product-derived therapy for overcoming chemoresistance in Human cancers: Honokiol increases the expression of CADM1, decreases BMI1 translocation, increases tumor suppressor INK4a/p16 expression and restores chemosensitivity in drug-resistant Human cancers via down regulation of its target gene, 18/December/2016, 11.01 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.